Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer
1 other identifier
observational
50
1 country
1
Brief Summary
Pancreatic cancer is a gastrointestinal tumor with a high degree of malignancy. Currently, there are many first-line chemotherapy regimens in clinical practice, but the individual selection of chemotherapy regimens has not been unanimously recognized.This study is aimed at exploring the correlation between the two-dimensional shear wave elastography (2D - SWE) parameters and pancreatic cancer stromal elements proportion through an ultrasound scan for resectable pancreatic cancer cases and postoperative pathological specimen analysis. Then determine if the pancreatic cancer two-dimensional shear wave elastography can guide clinicians selecting chemotherapy scheme by predicting tumor stromal elements .These results are expected to provide an effective non-invasive diagnostic basis for individualized treatment of pancreatic cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedJanuary 19, 2022
October 1, 2021
8 months
December 20, 2021
January 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Elastic modulus measured by Ultrasonic shear wave and tumor stromal component assessed by pathological analysis in pancreatic cancer
Baseline (Preoperative ultrasound elastography examination)
Interventions
Preoperative ultrasound elastography examination
Eligibility Criteria
Consecutive cases of pancreatic cancer in Xijing Hospital
You may qualify if:
- Patients with resectable pancreatic cancer underwent ultrasound examination before surgery
- Conventional ultrasound can clearly show pancreatic space-occupying lesions and the elastic measurements show good images
- The patient agrees to receive ultrasound elasticity examination and signs informed consent
- All patients had no history of radiotherapy or chemotherapy before ultrasound examination
- All clinical case data and auxiliary examination data are complete and accessible.
You may not qualify if:
- Ultrasound evaluation was not performed before ultrasound-guided needle biopsy
- Conventional ultrasound could not clearly show pancreatic space-occupying lesions or poor elastic measurement images
- Patients who refuse to accept examination or give up treatment
- Patients receiving neoadjuvant chemotherapy or radiotherapy before ultrasound examination
- Incomplete clinical data and auxiliary examination data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
Study Sites (1)
Xijing Hospital
Xi'an, Shaanxi, 710032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2021
First Posted
January 11, 2022
Study Start
February 1, 2022
Primary Completion
October 1, 2022
Study Completion
October 1, 2022
Last Updated
January 19, 2022
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share